[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fO0glwFH8cEwYpClndK2Sl4hrp21a64eNI3HQS9uaAv4":8,"$fz-aY-v2L4vglW82bukchmGfCAdmVZNhtwqcNDhlXCCo":55,"$fgNPeRRASg2xQaAsDrNr2S6iiNiObgKNig1wMS2TK2F4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65692,869176,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//tYNYhJAqDhmdUE00JOKZqkpDppbQDUIW.png","王鹏","凤城市中心医院","肿瘤科","副主任医师",9,0,"乳腺癌早期治疗：术后化疗方案解析 🧑‍⚕️","","https://ystcdn.venuertc.com/venue/AI/c2187f4a-acd8-4c8a-89f2-d3f9282787c2.jpg","\n\u003Cdiv class=\"custom-material-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"custom-material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌早期治疗：术后化疗方案解析 🧑‍⚕️\u003C/h2>\n  \n  \u003C!-- 开头简介 -->\n  \u003Csection class=\"custom-material-section custom-material-section-intro\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Cp class=\"custom-material-text\">\n        其实，很多人对于术后化疗的用药了解并不深入。化疗药物不仅种类多，细节也很关键。用于乳腺癌早期治疗的术后化疗药，像常见的AC-T等方案，其用法、剂量调整和注意事项直接影响疗程效果和安全性。本篇文章将深入解析这些药品的 \u003Cspan class=\"custom-material-highlight\">7个核心用药细节\u003C/span>，帮你实实在在掌握安全用药方法。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 01 剂型与成分：化疗方案用药有哪些？ -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型与成分：术后化疗常用药有哪些？ 💊\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>多柔比星（Doxorubicin）：\u003C/strong>注射剂型。属于蒽环类，通过干扰DNA复制、杀灭异常细胞。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>环磷酰胺（Cyclophosphamide）：\u003C/strong>注射剂型。烷化剂，破坏细胞遗传物质，阻止细胞分裂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>紫杉醇（Paclitaxel）：\u003C/strong>注射用。属于紫杉类，通过稳定微管结构，抑制细胞分裂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>多西他赛（Docetaxel）：\u003C/strong>注射制剂，与紫杉醇类似，主要也是药物注射入静脉。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip custom-material-tip-fluid\">\n        正确做法：这类药物都是静脉注射，必须由专业医护人员操作。自行使用有风险，不建议家中自行处理。\n      \u003C/div>\n      \u003Cdiv class=\"custom-material-inline-case\">\n        临床上，60岁女性在完成3周期AC-T方案后，因出现粒细胞缺乏而调整了剂量。正确调整后化疗顺利完成。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 02 药理机制：这些药物如何发挥效果？ -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药理机制：这些药物是怎么发挥作用的？🧬\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>多柔比星：\u003C/strong>插入DNA链，阻断细胞复制，让异常细胞无法继续分裂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>环磷酰胺：\u003C/strong>形成化学交联，破坏遗传信息，直接杀死细胞。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>紫杉醇/多西他赛：\u003C/strong>让细胞微管“卡住”，细胞分裂受阻，异常细胞逐渐死亡。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip\">\n        需要注意：这些机制也导致了部分正常细胞受影响，因此副作用较为常见。\n      \u003C/div>\n      \u003Cdiv class=\"custom-material-data\">\n        临床研究显示，蒽环类药物与紫杉类药物组合用于术后化疗，有效率可达70%-80%（Jones, SE et al., J Clin Oncol, 2006）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 正确用法与用量：怎么用药才安全？ -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 正确用法与用量：化疗药怎么用才安全？🔔\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>剂量：\u003C/strong>必须严格按方案，通过体表面积及肝肾功能等综合决定，由医生设定。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>周期：\u003C/strong>常见为每3周一次，每次用药有间隔，整个疗程多为4-8周期。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>用药流程：\u003C/strong>每次都应有详细的血常规等检查，出现粒细胞显著下降时，按需调整剂量或延后下次治疗。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip custom-material-tip-fluid\">\n        特别提醒：不可自行提前或延后用药。感觉身体正常，并不代表血细胞没有异常。\n      \u003C/div>\n      \u003Cdiv class=\"custom-material-inline-case\">\n        有位患者因粒细胞短期下降，医生及时调整了多柔比星与环磷酰胺的剂量，成功避免了进一步风险。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 04 药物相互作用：哪些药物不能同用？ -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用：哪些药品不能一起用？🔄\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>蒽环类（多柔比星）与已知心脏毒性药物：\u003C/strong>如部分抗生素（比如阿霉素类）同时用会增加心脏损伤风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>紫杉类与CYP450抑制剂：\u003C/strong>如酮康唑、红霉素等抗真菌药、抗生素，会增强紫杉类药物血中浓度，易致副作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>环磷酰胺与肝酶诱导剂：\u003C/strong>如苯妥英钠、利福平等，可能减少环磷酰胺效果，或反而加重毒性。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip custom-material-tip-fluid\">\n        正确做法：服药前主动向医生报备所有在服用的药品与膳食补充剂。出现新的用药需求时必须再次核查药物安全性。\n      \u003C/div>\n      \u003Cdiv class=\"custom-material-data\">\n        数据表明，多柔比星与部分抗真菌药联用时不良反应风险提升20%（Smith, LA et al., Cancer Chemother Pharmacol, 2007）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 05 常见不良反应与应对方法 -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 不良反应：化疗药副作用常见吗？🤕\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>造血系统：\u003C/strong>粒细胞缺乏，易感染；出现此类情况应立即向医护人员报告，不可拖延。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>消化道反应：\u003C/strong>恶心、呕吐较常见，部分药可预防，仅短时间内出现。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>脱发与疲劳：\u003C/strong>紫杉类药物可能导致脱发，部分人有明显乏力感。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>局部反应：\u003C/strong>静脉注射后可出现红肿，若药液渗漏必须及时处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>严重反应：\u003C/strong>如出现持续高烧、剧烈腹泻/呕吐无法缓解，必须立即就医。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip\">\n        正确做法：确认不良反应后及时处理，绝不自行服用对症药物缓解严重副作用，避免延误诊断。\n      \u003C/div>\n      \u003Cdiv class=\"custom-material-inline-case\">\n        某患者第三周期注射后因粒细胞缺乏，未出现感染，说明周期性监测至关重要。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 用药禁忌与特殊群体用药调整 -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 用药禁忌及特殊群体注意 🚫\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>特殊人群：\u003C/strong>肝、肾功能受损者应严格调整剂量，部分药物如多柔比星严重肝衰竭时禁用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>妊娠：\u003C/strong>妊娠妇女禁用，药品可能对胎儿有致畸风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>哺乳期：\u003C/strong>哺乳期女性不可使用多柔比星等药物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过敏体质：\u003C/strong>发现注射过程有明显皮疹、呼吸急促等过敏反应，需立即停药并快速就医。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>老年患者：\u003C/strong>根据个体耐受性调整剂量，监测副作用更频繁。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip custom-material-tip-fluid\">\n        必须避免：自行增减药量或缩短疗程，这些调整会影响疗效，也易出现危险反应。\n      \u003C/div>\n      \u003Cdiv class=\"custom-material-data\">\n        说明书提示：多柔比星、环磷酰胺在肝肾功能异常者用量严格受限（FDA, 2022）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 保存方式与过期处理 -->\n  \u003Csection class=\"custom-material-section\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存方法与用药遗忘应对 📦\u003C/h2>\n      \u003Cul class=\"custom-material-list\">\n        \u003Cli>\n          \u003Cstrong>储存：\u003C/strong>所有注射剂需2-8°C冷藏，避免阳光直射，不可冷冻。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>开封：\u003C/strong>一旦开封，药液需限时用完，剩余药品必须按医嘱正规处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过期：\u003C/strong>过期或变色药物不可再用，应交由医院或药店统一回收。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>漏服或错服：\u003C/strong>化疗药物必须全程由医护人员管理，无自行补服的说法。若中断或漏服，必须及时报告医生，根据方案调整，无需自行补用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"custom-material-tip\">\n        正确做法：家中不可存放大量余药，避免误用，放置高处或专用药箱，不让儿童接触。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 结尾与用药建议总结 -->\n  \u003Csection class=\"custom-material-section custom-material-section-conclusion\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语 ✨\u003C/h2>\n      \u003Cp class=\"custom-material-text\">\n        用于乳腺癌术后的化疗药物，关键在于剂型、用法、剂量、相互作用和不良反应监测。无论是哪一种化疗方案，都必须由专业团队操作和管理，切忌自行服用或随意调整。\u003Cspan class=\"custom-material-highlight\">最重要的是，化疗药品的用量、周期和组合不可变更\u003C/span>，任何感到身体不适或出现副作用都应就医。安全用药，是保证良好效果和减少风险的前提。\n      \u003C/p>\n      \u003Cp class=\"custom-material-text\">\n        家人如有用药需求，应及时咨询医生药师，不要随便听信非专业人士建议，让正确用药成为健康保障的第一步。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 文献引用 -->\n  \u003Csection class=\"custom-material-section custom-material-section-ref\">\n    \u003Cdiv class=\"custom-material-subbg\">\n      \u003Ch2 class=\"custom-material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 📚\u003C/h2>\n      \u003Col class=\"custom-material-ref-list\">\n        \u003Cli>\n          Jones, S. E., Erban, J., Overmoyer, B., Budd, G. T., Hutchins, L., Lower, E. E., ... &amp; Natale, R. B. (2006). Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. \u003Cem>Journal of Clinical Oncology\u003C/em>, 24(22), 3672-3679.\n        \u003C/li>\n        \u003Cli>\n          Smith, L. A., Cornelius, V. R., Plummer, C. J., Levitt, G., Verrill, M., Canney, P., ... &amp; Jones, A. (2007). Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. \u003Cem>Cancer Chemotherapy and Pharmacology\u003C/em>, 60(4), 501-516.\n        \u003C/li>\n        \u003Cli>\n          U.S. Food &amp; Drug Administration (FDA). (2022). DOXORUBICIN-Injection [Product Information]. \u003Ca href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/50754s017lbl.pdf\" class=\"custom-material-link\" target=\"_blank\">FDA Label\u003C/a>.\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n  \n\u003C/div>\n\u003Cstyle>\n.custom-material-wrapper {\n  font-family: \"PingFang SC\", \"Arial\", \"Helvetica Neue\", sans-serif;\n  background: #f9fafb;\n  margin: 0px auto;\n  padding: 32px 12% 64px 12%;\n  box-sizing: border-box;\n  max-width: 900px;\n  min-width: 360px;\n  color: #222;\n  border-radius: 16px;\n  box-shadow: 0px 6px 22px rgba(54, 132, 242, 0.05);\n}\n\n.custom-material-title {\n  font-size: 2.4em;\n  font-weight: 600;\n  color: #3e5d99;\n  margin-bottom: 18px;\n  border-left: 8px solid #70aeff;\n  padding-left: 16px;\n}\n\n.custom-material-section {\n  margin-bottom: 32px;\n}\n\n.custom-material-section-intro {\n  margin-top: 0px;\n  margin-bottom: 38px;\n}\n\n.custom-material-section-conclusion {\n  margin-bottom: 12px;\n}\n\n.custom-material-subbg {\n  background: linear-gradient(90deg, #e6f3ff 55%, #f5f7fa 100%);\n  padding: 24px 22px 24px 24px;\n  border-radius: 14px;\n  box-shadow: 0px 1px 6px rgba(107, 160, 241, 0.07);\n}\n\n.custom-material-subtitle {\n  font-size: 1.35em;\n  font-weight: 570;\n  margin-bottom: 18px;\n  color: #2878c0;\n  letter-spacing: 0.5px;\n  text-shadow: 1px 2px 6px #e7eefa;\n  margin-top: 0px;\n}\n\n.custom-material-list {\n  list-style: disc inside;\n  margin: 0px 0px 12px 0px;\n  padding: 0px 0px 0px 12px;\n  font-size: 1em;\n}\n\n.custom-material-list li {\n  margin-bottom: 8px;\n  line-height: 2;\n}\n\n.custom-material-tip {\n  background: #fff4e3;\n  border-left: 5px solid #fbb137;\n  color: #8a5205;\n  margin: 16px 0px 6px 0px;\n  padding: 12px 15px;\n  border-radius: 8px;\n  font-size: 0.98em;\n  box-shadow: 0px 1px 5px #f7e3c2;\n  font-weight: 500;\n}\n\n.custom-material-tip-fluid {\n  background: linear-gradient(90deg, #fff6e1 60%, #f8ecd1 100%);\n}\n\n.custom-material-inline-case {\n  background: #e9f6e1;\n  border-left: 5px solid #83ca6c;\n  color: #435922;\n  padding: 10px 16px;\n  margin: 10px 0px 4px 0px;\n  font-size: 0.96em;\n  border-radius: 8px;\n  box-shadow: 0px 1px 5px #dbeed4;\n}\n\n.custom-material-data {\n  background: #e0f2fc;\n  border-left: 5px solid #5db7ea;\n  color: #216177;\n  padding: 10px 14px;\n  margin: 12px 0px 8px 0px;\n  font-size: 0.97em;\n  border-radius: 8px;\n  box-shadow: 0px 1px 5px #d0e7f6;\n}\n\n.custom-material-ref-list {\n  padding-left: 12px;\n  margin: 0px;\n  font-size: 0.98em;\n}\n\n.custom-material-ref-list li {\n  margin-bottom: 8px;\n  word-break: break-word;\n  line-height: 1.7;\n}\n\n.custom-material-link {\n  color: #2677bf;\n  text-decoration: underline dotted;\n  font-weight: 480;\n}\n\n.custom-material-highlight {\n  background: linear-gradient(90deg, #fff7b2 60%, #ffeab8 100%);\n  color: #d76e00;\n  padding: 2px 8px;\n  border-radius: 6px;\n  margin: 0px 2px;\n  font-weight: 620;\n  font-size: 1.08em;\n}\n\n.custom-material-text {\n  font-size: 1.1em;\n  line-height: 2.2;\n  margin-bottom: 8px;\n  margin-top: 2px;\n  color: #153466;\n}\n\n@media screen and (max-width: 640px) {\n  .custom-material-wrapper {padding: 24px 4% 36px 4%;}\n  .custom-material-title {font-size: 1.5em;}\n  .custom-material-section {margin-bottom: 18px;}\n  .custom-material-subbg {padding: 16px 8px 15px 12px;}\n  .custom-material-subtitle {font-size: 1.08em;}\n}\n\u003C/style>\n\n","\n\u003Cdiv class=\"custom-material-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"custom-material-title\" style",516,"2025-09-04 14:55:20","乳腺癌, 术后化疗, 化疗药物, 不良反应, 用药安全","深入解析乳腺癌术后化疗药物的7个核心用药细节，了解用药安全、剂量调整与副作用，助力患者有效治疗与规避风险。","2025-09-08 11:15:28",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]